Resurrect Bio
—
SectorsTechnology2
RegionsEurope1
Last activity
Activity, last 12 months
| Month | Events |
|---|---|
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 1 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 1 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
Deal history
Resurrect Bio raises EUR 8.8m for crop resilience
UK agribiotech Resurrect Bio has closed a EUR 8.8 million Series A backed by Corteva and a syndicate of specialist investors to advance disease-resistant crop development.
Corteva leads Resurrect Bio $8.1m Series A
Resurrect Bio has raised $8.1 million in a Series A led by Corteva Agriscience, backing its gene-editing platform to restore suppressed disease resistance in crops and reduce reliance on chemical crop protection.